Altimmune ALT
NASDAQ ALT
$2.73 -0.03 (-0.91%)
At close: Oct 2, 2026 · 4:00 PM EDT

Altimmune (ALT) Dividends Paid - Common and Prefferd (2017)

Updated

Altimmune's Dividends Paid - Common and Prefferd was $200.25 million in Q1 2017.

Analysis

Altimmune (ALT) Dividends Paid - Common and Prefferd (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div Paid (Total) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 3.23 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.07 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.14 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.87 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -1.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.36 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.03 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.45 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Altimmune 556.20 Mn 556.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 200.25 Mn
API Access

Altimmune Dividends Paid - Common and Prefferd API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-paid-common-and-prefferd&ticker=ALT&period=max&api_key=YOUR_API_KEY